Afamelanotide in the Treatment of Dermatologic Disease

07:00 EST 21 Jan 2019 | Medscape

Review the pharmacokinetics and potential applications for afamelanotide, an alpha-melanocyte stimulating hormone analogue, which is emerging as a therapeutic option for a variety of skin conditions.
Skin Therapy Letter

Original Article: Afamelanotide in the Treatment of Dermatologic Disease

More From BioPortfolio on "Afamelanotide in the Treatment of Dermatologic Disease"